DK1536836T3 - Topisk emulsionsgelsammensætning indeholdende diclofenacnatrium - Google Patents

Topisk emulsionsgelsammensætning indeholdende diclofenacnatrium

Info

Publication number
DK1536836T3
DK1536836T3 DK03792412T DK03792412T DK1536836T3 DK 1536836 T3 DK1536836 T3 DK 1536836T3 DK 03792412 T DK03792412 T DK 03792412T DK 03792412 T DK03792412 T DK 03792412T DK 1536836 T3 DK1536836 T3 DK 1536836T3
Authority
DK
Denmark
Prior art keywords
composition containing
gel composition
diclofenac sodium
emulsion gel
containing diclofenac
Prior art date
Application number
DK03792412T
Other languages
English (en)
Inventor
Michel Steiger
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31896841&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1536836(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Application granted granted Critical
Publication of DK1536836T3 publication Critical patent/DK1536836T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
DK03792412T 2002-08-22 2003-08-21 Topisk emulsionsgelsammensætning indeholdende diclofenacnatrium DK1536836T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02018772 2002-08-22
PCT/EP2003/009302 WO2004017998A2 (en) 2002-08-22 2003-08-21 Topical emulsion- gel composition comprising diclofenac sodium

Publications (1)

Publication Number Publication Date
DK1536836T3 true DK1536836T3 (da) 2008-07-21

Family

ID=31896841

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03792412T DK1536836T3 (da) 2002-08-22 2003-08-21 Topisk emulsionsgelsammensætning indeholdende diclofenacnatrium

Country Status (16)

Country Link
US (3) US7732489B2 (da)
EP (1) EP1536836B1 (da)
AR (1) AR041021A1 (da)
AT (1) ATE390149T1 (da)
AU (1) AU2003264086B2 (da)
BR (1) BR0313701A (da)
CA (1) CA2496469C (da)
DE (1) DE60319997T2 (da)
DK (1) DK1536836T3 (da)
ES (1) ES2300645T3 (da)
MX (1) MXPA05002077A (da)
PE (1) PE20040321A1 (da)
PT (1) PT1536836E (da)
SI (1) SI1536836T1 (da)
TW (1) TWI316857B (da)
WO (1) WO2004017998A2 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1588697A1 (en) * 2004-04-16 2005-10-26 Kurt H. Prof. Dr. Bauer Emulsion gel for topical application of pharmaceuticals
FR2882552B1 (fr) * 2005-02-25 2008-12-26 Galderma Sa Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
WO2006116661A2 (en) * 2005-04-27 2006-11-02 Avocet Polymer Technologies, Inc. Polyethylene glycol based composition for topical treatment of a closed wound with therapeutic pharmaceuticals
WO2008032227A2 (en) 2006-09-11 2008-03-20 Biomas, Ltd. Topical formulations of tellurium-containing compounds
BRPI0717769A2 (pt) 2006-10-17 2013-11-05 Nuvo Res Formulação de gel, método para o tratamento da osteoartrite em um indivíduo sofrendo de dor articular, e, uso de diclofenac de sódio
GB0704846D0 (en) * 2007-03-13 2007-04-18 Futura Medical Dev Ltd Topical pharmaceutical formulation
DE102007034976A1 (de) 2007-07-26 2009-01-29 Bayer Healthcare Ag Arzneimittel zur transdermalen Anwendung bei Tieren
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
US20100099766A1 (en) * 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
US20100100060A1 (en) * 2008-10-17 2010-04-22 Novartis Ag Applicator for pharmaceutical product and method of using same
DE102009008094A1 (de) * 2009-02-09 2010-08-19 Barnikol-Keuten, Doris, Dr. In situ Haft-Gelbildende Zubereitungen, insbesondere zur topischen Anwendung auf befeuchtete Haut/Schleimhaut
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
AU2010233343A1 (en) 2009-04-08 2011-10-27 Cadila Healthcare Limited Stable pharmaceutical compositions of diclofenac
PL2512446T3 (pl) * 2009-12-16 2015-08-31 Shasun Pharmaceuticals Ltd Kompozycja transdermalnego hydrożelu z deksibuprofenem
US9713590B2 (en) 2011-07-28 2017-07-25 Cadila Healthcare Limited Method for treatment of pain and inflammation
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
WO2014009241A1 (en) 2012-07-12 2014-01-16 Ferring B.V. Diclofenac formulations
RU2702898C2 (ru) 2014-09-10 2019-10-14 Гск Консьюмер Хелткер С.А. Композиции диклофенака натрия для местного применения
GB201502845D0 (en) 2015-02-20 2015-04-08 Futura Medical Dev Ltd Topical pharmaceutical formulation
JP6598619B2 (ja) * 2015-09-28 2019-10-30 株式会社ポーラファルマ 物性で特定される皮膚外用剤
FR3064495B1 (fr) 2017-03-31 2021-04-02 Total Marketing Services Composition a base d'uree pour le traitement des gaz d'echappement
WO2023052599A1 (en) 2021-10-01 2023-04-06 Nutrition & Biosciences Usa 1, Llc Hydrocolloid blend compositions for topical application
WO2023180792A1 (en) 2022-03-25 2023-09-28 Glycores 2000 Srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (da) * 1982-10-07 1986-05-15
WO1992007561A1 (fr) * 1990-10-30 1992-05-14 Ss Pharmaceutical Co., Ltd. Preparation d'un gel anti-inflammatoire et analgesique
CA2112751A1 (en) * 1991-07-03 1993-01-21 Charles J. Ii Betlach Composition and method for transdermal delivery of diclofenac
US5399342A (en) * 1993-02-03 1995-03-21 Dow Corning Corporation Cosmetics with enhanced durability
CN1210463A (zh) * 1996-02-07 1999-03-10 株式会社津村 透明双氯芬酸钠的水溶液以及它的药物组合物
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
TWI290464B (en) 2000-09-01 2007-12-01 Novartis Consumer Health Sa Treatment of burns
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition

Also Published As

Publication number Publication date
US7732489B2 (en) 2010-06-08
BR0313701A (pt) 2005-06-28
AR041021A1 (es) 2005-04-27
SI1536836T1 (sl) 2008-08-31
EP1536836A2 (en) 2005-06-08
DE60319997D1 (de) 2008-05-08
TW200409646A (en) 2004-06-16
US20050239894A1 (en) 2005-10-27
ATE390149T1 (de) 2008-04-15
CA2496469A1 (en) 2004-03-04
ES2300645T3 (es) 2008-06-16
WO2004017998A3 (en) 2004-04-01
DE60319997T2 (de) 2009-04-30
AU2003264086B2 (en) 2007-01-04
PE20040321A1 (es) 2004-07-15
EP1536836B1 (en) 2008-03-26
TWI316857B (en) 2009-11-11
US20100234462A1 (en) 2010-09-16
CA2496469C (en) 2011-07-05
PT1536836E (pt) 2008-05-09
WO2004017998A2 (en) 2004-03-04
US20140045942A1 (en) 2014-02-13
MXPA05002077A (es) 2005-06-08
US8716340B2 (en) 2014-05-06
US8557870B2 (en) 2013-10-15
AU2003264086A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
DK1536836T3 (da) Topisk emulsionsgelsammensætning indeholdende diclofenacnatrium
NO343756B1 (no) Gelformulering med oksybutynin for utildekket topisk anvendelse
FR2842417B1 (fr) Composition cosmetique
FR2842416B1 (fr) Composition cosmetique
DE60325255D1 (de) Duftzusammensetzung
DE60334165D1 (de) Härtbare Zusammensetzung
DE10393374D2 (de) Zusammensetzung
DE60333311D1 (de) Kosmetische zusammensetzung
NO20052952D0 (no) Farmasoytisk sammensetning som innbefatter mikropartikler
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
DE60316102D1 (de) Einkomponentige Organopolysiloxangelzusammensetzung
DE60311694D1 (de) Kosmetische Zusammensetzung
SE0500163L (sv) Sammansättning
IS2616B (is) Lyfjablanda sem felur í sér levóþýroxínnatríum
ATE309789T1 (de) Darreichungsform von ibuprofen-natrium
IS7715A (is) Nýjar lyfjasamsetningar úr módafíníl
FR2831433B1 (fr) Composition topique solide
DK1611884T3 (da) Plaster, indeholdende diclofenac
PT1558263E (pt) Composicao farmaceutica de libertacao prolongada
DE60303836D1 (de) Haarglättungszusammensetzung
DE602004018858D1 (de) Emulsionszusammensetzung
DE60326900D1 (de) Duftstoff-Zusammensetzung
NO20024880D0 (no) Sammensetning inneholdende fosfat
IS7902A (is) Blettaeyðandi samsetning fyrir húðumhirðu
NO20044140D0 (no) New Composition